Related Experiment Video

Updated: May 24, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Pediatric oncology palliative care in Israel

Isaac Yaniv1

  • 1Israeli Society of Pediatric Hematology Oncology, Pediatric Hematology Oncology Division, Schneider Children's Medical Center of Israel, Petach Tikva, Israel. iyaniv@clalit.org.il

Journal of Pediatric Hematology/Oncology
|February 24, 2012
PubMed

Insights

Pediatric cancer care in Israel has significantly advanced, matching international outcomes. The system addresses diagnosis delays, late effects, and end-of-life care for 450 children annually.

Area of Science:

  • Pediatric Oncology
  • Cancer Research
  • Healthcare Systems Analysis

Background:

  • Pediatric oncology in Israel has evolved over 40 years.
  • Current outcomes for childhood cancer in Israel align with international standards.
  • Approximately 450 new pediatric cancer cases are diagnosed and treated yearly in specialized centers.

Purpose of the Study:

  • To describe the Israeli healthcare system for pediatric oncology.
  • To focus on critical aspects: delay in diagnosis, late effects of treatment, palliative care, and end-of-life care.
  • To outline achievements and identify challenges in improving patient care.

Main Methods:

  • Descriptive analysis of the Israeli pediatric oncology healthcare system.
  • Review of data concerning diagnosis timelines, treatment outcomes, and supportive care services.
  • Identification of key challenges and future objectives.

Main Results:

  • Childhood cancer survival rates in Israel are comparable to major international cooperative groups.
  • The healthcare system provides specialized care for 450 children annually.
  • Specific attention is given to managing diagnostic delays, late effects, and end-of-life care.

Conclusions:

  • Israel has achieved significant progress in pediatric oncology, offering care that meets global benchmarks.
  • Ongoing efforts focus on refining the healthcare system to address diagnostic delays, late effects, and end-of-life care.
  • Future goals aim to further enhance patient outcomes and quality of care in pediatric oncology.

More Related Videos

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma09:06

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

Published on: November 11, 2021

Isolation and Characterization of Neutrophils with Anti-Tumor Properties10:15

Isolation and Characterization of Neutrophils with Anti-Tumor Properties

Published on: June 19, 2015

Related Concept Videos

Continuing Care01:25

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...